Xing Naidong, Wang Hongyan, Huang Yan, Peng Jin
Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Front Med (Lausanne). 2023 Apr 17;10:1057923. doi: 10.3389/fmed.2023.1057923. eCollection 2023.
To evaluate the efficacy of the enhanced recovery after surgery (ERAS) programs on the systemic inflammatory response (SIR) of patients following gynecological surgery, a randomized controlled trial was performed to compare the ERAS programs with the conventional perioperative care programs. Furthermore, novel SIR markers could be identified to evaluate the ERAS programs of gynecological surgery.
Patients undergoing gynecological surgery were randomly allocated to either the ERAS group or the conventional group. The correlations between the elements of ERAS protocols and SIR markers following gynecological surgery were evaluated.
A total of 340 patients who underwent gynecological surgery were enrolled (ERAS = 170; conventional = 170). First, we identified whether the ERAS programs after gynecological surgery reduced the perioperative difference between neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR). Interestingly, first flatus time postoperatively, visual analog scale (VAS) score of patients was positively correlated with the perioperative difference NLR or PLR. Moreover, we discovered that the perioperative difference NLR or PLR was correlated with elements of ERAS protocol, including first sips of water, first semifluid diet postoperatively, pelvic drain duration, and out-of-bed time of patients.
We originally reveal that certain elements of ERAS programs alleviated SIR to operation. The implementation of ERAS programs enhances postoperative recovery after gynecological surgery improving system inflammatory status. NLR or PLR could be the novel and inexpensive marker to assess ERAS programs in gynecological surgery.ClinicalTrials.gov, identifier, NCT03629626.
为评估手术加速康复(ERAS)方案对妇科手术后患者全身炎症反应(SIR)的疗效,进行了一项随机对照试验,比较ERAS方案与传统围手术期护理方案。此外,可识别新的SIR标志物以评估妇科手术的ERAS方案。
将接受妇科手术的患者随机分为ERAS组或传统组。评估ERAS方案要素与妇科手术后SIR标志物之间的相关性。
共纳入340例接受妇科手术的患者(ERAS组 = 170例;传统组 = 170例)。首先,我们确定妇科手术后的ERAS方案是否缩小了中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)的围手术期差异。有趣的是,术后首次排气时间、患者的视觉模拟评分(VAS)与围手术期NLR或PLR差异呈正相关。此外,我们发现围手术期NLR或PLR差异与ERAS方案要素相关,包括首次饮水、术后首次半流质饮食、盆腔引流持续时间和患者下床时间。
我们首次揭示ERAS方案的某些要素减轻了手术的SIR。ERAS方案的实施促进了妇科手术后的恢复,改善了全身炎症状态。NLR或PLR可能是评估妇科手术ERAS方案的新型且廉价的标志物。ClinicalTrials.gov标识符:NCT03629626。